摘要:
The invention relates to the use of acylated 4-amidino- or 4-guanidinobenzylamines of general formula (I): P4-P3-P2-P1, where P4 is a mono- or poly-substituted or unsubstituted benzylsulphonyl group, P3 is a mono- or poly-substituted or unsubstituted, natural or unnatural α-amino or α-imino acid with the D-configuration, P2 is a mono-or poly-substituted or unsubstituted natural or unnatural α-amino or α-imino acid with the L-configuration and P1 is a mono- or poly-substituted or unsubstituted 4-amidino- or 4-guanidinobenzylamine group, for the inhibition of plasma kallikrein (PK), factor XIa and factor XIIa, in particular for the prevention of coagulation activation on synthetic surfaces and for systemic dosage as anticoagulants/antithrombotics, above all for prevention of coagulation activation on synthetic surfaces to prevent thromboembolic events.
摘要:
A tubular or spherical nanostructure composed of a plurality of peptides, wherein each of the plurality of peptides includes no more than 4 amino acids and whereas at least one of the 4 amino acids is an aromatic amino acid.
摘要:
A melanin eliminator preparation comprising a metal chelate compound represented by the following formula (I), wherein M denotes a metal, and R denotes hydroxyl, O-lower alkyl, an amine bonded at N, an amino acid bonded at N, or a peptide bonded at N, or a pharmacologically acceptable salt thereof.
摘要:
A gene, which codes for a tumor antigen that is recognized by a cytotoxic T-lymphocyte (CTL) and/or induces a CTL in an HLA-A2-restricted manner, was isolated from a cDNA library of the human glioma cell strain KNS60 and identified. In addition, a peptide having the epitope of the tumor antigen was found, based on the tumor antigen coded by the gene obtained.
摘要:
The present invention comprises small molecular weight, non-peptidic inhibitors of formula (I) and (II) of Protein Tyrosine Phosphatase 1 (PTP1) which are useful for the treatment and/or prevention of Non-Insulin Dependent Diabetes Mellitus (NIDDM).
摘要:
The present invention is based on the unexpected discovery that activated protein C (APC) is inactivated by copper. Accordingly, the invention provides improved methods of treating diseases and conditions treatable with APC which utilize a copper chelator to inhibit the inactivation of APC by copper.
摘要:
Compounds represented by general formula (I), (wherein n is 1 or 2; R1 represents C¿3-10? cycloalkyl, optionally carboxylated C1-10 alkyl, etc.; R?2¿ represents hydrogen, C¿1-10? alkyl, etc.; and R?3¿ represents amino or amidino), for example, trans-4-amino[(S)-N-[(S)-2-propoxycarbonylamino-3-isopropylthio-3-methyl-butanoyl]prolyl]aminomethylcyclohexane. Because of having a potent inhibitory activity on thrombin, such compounds are useful as an anticoagulant.
摘要:
Peptide compounds of formula (I). Peptides are inhibitors of (matrix) metalloproteinases like collagenase and stromelysin. Furthermore, they inhibit the liberation of tumor necrosis factor alpha (TNF alpha ).